Stablepharma and AFT Pharmaceuticals partner to address multi-billion dollar anti-infective and oncology market

Stablepharma Announces Database Lock for Fridge-Free Tetanus-Diphtheria Vaccine Clinical Trial

Revolutionising global vaccine access: The case for Stablepharma’s fridge-free vaccine technology

Stablepharma enters Phase 1 Clinical Trials with world-first Fridge-Free Td Vaccine

BIA Spotlight: how Stablepharma is pioneering the world’s first fridge-free Td vaccine

Stablepharma Receives MHRA Approval for Phase 1 Trial of Fridge-Free Tetanus & Diphtheria (Td) Vaccine

Dr Kenny Simmen named Chief Business Officer of Stablepharma Ltd

Stablepharma Secures €2.5m EIC Grant, recognised Among Europe’s Top 71 Innovators

Stablepharma named a Fierce Innovation Awards Winner!

Stablepharma & AJ Vaccines sign strategic LoI to distribute and commercialise Fridge-free Vaccines

Stablepharma nominated Finalist in Pharma Industry Awards UK 2024 – The Times

Dr. Steven Chatfield appointed as Non-Executive Chairman of Stablepharma Ltd